MedTrace Logo

Interest of Combining Speech Therapy With a Non-invasive Brain Stimulation (tDCS) for the Aphasic Patient

NCT02612753 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-07-26

No results posted yet for this study

Summary

Aphasia is a frequent symptom after a left hemisphere stroke. It has serious impacts on social, family and professional lives. Aphasic patients need to be rehabilitated. To date, no pharmacological treatment being available only speech and language therapy (SLT) can improve patients, but its efficiency is moderate. Several studies have investigated the link between the recovery of language and neural reorganization. tDCs, a noninvasive technology for modulating neural excitability, could potentiate the effects of the SLT. About 25 studies in literature have described beneficial effects of tDCs coupled with SLT on aphasic patients. However to the investigator knowledge the feasibility of tDCs and speech therapy in clinical pathways has never been investigated. That is why the investigator propose to study in real care conditions how SLT proves more efficient on the recovery of language in a discursive assessment when coupled with active stimulation than with placebo stimulation.

Conditions

  • Aphasia

Interventions

PROCEDURE

improvement of language for aphasics patients

Aphasics patients receive active stimulation during SLT

DEVICE

Sham tDCS

Aphasics patients control receive sham stimulation during SLT

DEVICE

tDCs

Sponsors & Collaborators

  • Fondation Paul Bennetot

    collaborator OTHER

  • Fondation Garches

    collaborator OTHER

  • Centre d'Investigation Clinique et Technologique 805

    lead OTHER

Principal Investigators

  • Philippe AZOUVI, MDPHD · Hopital RAYMOND POINCARE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-11-30
Completion
2018-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02612753 on ClinicalTrials.gov